These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 13598369)

  • 21. [Action of the thioamide of alpha-ethylisonicotinic acid on the morphology of Mycobacterium tuberculosis (research by electron microscopy)].
    NITTI V; VIRGILIO R
    Riv Ist Sieroter Ital; 1960; 35():515-28. PubMed ID: 13729298
    [No Abstract]   [Full Text] [Related]  

  • 22. Drug resistance profile of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Jos, Nigeria.
    Ani AE; Idoko J; Dalyop YB; Pitmang SL
    Trans R Soc Trop Med Hyg; 2009 Jan; 103(1):67-71. PubMed ID: 18789463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study of drug resistant cases among new pulmonary tuberculosis patients attending a tuberculosis center, Yangon, Myanmar.
    Aung WW; Ti T; Than KK; Thida M; Nyein MM; Htun YY; Maung W; Htun A
    Southeast Asian J Trop Med Public Health; 2007 Jan; 38(1):104-10. PubMed ID: 17539254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Status of antituberculosis drug resistance in Saudi Arabia 1979-98.
    Abu-Amero KK
    East Mediterr Health J; 2002; 8(4-5):664-70. PubMed ID: 15603050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro inhibitory effect of antituberculosis drugs on clinical and environmental strains of Coccidioides posadasii.
    de Aguiar Cordeiro R; Brilhante RS; Rocha MF; Fechine MA; Camargo ZP; Sidrim JJ
    J Antimicrob Chemother; 2006 Sep; 58(3):575-9. PubMed ID: 16867997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of pulmonary tuberculosis with high dosage of isoniazid derivative (Na-methansulfonate-IHMS) combined with PAS. The results of primary treatment of infiltrative caseous lesions].
    OHSATO T
    Kekkaku; 1960 Oct; 35():668-74. PubMed ID: 13730529
    [No Abstract]   [Full Text] [Related]  

  • 27. Recent advances in the medical and surgical treatment of multi-drug resistant tuberculosis.
    Lalloo UG; Naidoo R; Ambaram A
    Curr Opin Pulm Med; 2006 May; 12(3):179-85. PubMed ID: 16582672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Retrosternal lymphotropic chemotherapy and pneumoperitoneum in the treatment of drug-resistant destructive pulmonary tuberculosis].
    Kibrik BS; Zakharov AV; Lobanovskiĭ VM
    Probl Tuberk Bolezn Legk; 2009; (5):21-6. PubMed ID: 19565808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends in drug-resistant Mycobacterium tuberculosis in New York City, 1991-2003.
    Munsiff SS; Li J; Cook SV; Piatek A; Laraque F; Ebrahimzadeh A; Fujiwara PI
    Clin Infect Dis; 2006 Jun; 42(12):1702-10. PubMed ID: 16705575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effectiveness of artificial pneumothorax in the treatment of patients with pulmonary tuberculosis with multiple drug-resistant Mycobacteria].
    Chukanov VI; Mishin VIu; Sigaev AT; Vasil'eva IA; Osadchaia OA; Perfil'ev AV; Naumova AN; Bagdasarian TR
    Probl Tuberk Bolezn Legk; 2004; (8):22-4. PubMed ID: 15478553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Drug resistance of Mycobacteria tuberculosis in patients with new-onset pulmonary tuberculosis].
    Khudushina TA; Voloshina EP; Adamovich NV; Maslakova MG; Terekhova ND
    Probl Tuberk Bolezn Legk; 2005; (12):37-9. PubMed ID: 16496762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current status and future prospects for new therapies for pulmonary tuberculosis.
    de Souza MV
    Curr Opin Pulm Med; 2006 May; 12(3):167-71. PubMed ID: 16582670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of isonicotinic acid N'-arylidene-N-[2-oxo-2-(4-aryl-piperazin-1-yl)-ethyl]-hydrazides as antituberculosis agents.
    Sinha N; Jain S; Tilekar A; Upadhayaya RS; Kishore N; Jana GH; Arora SK
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1573-6. PubMed ID: 15745799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New methodological instructions for grouping of contingents of patients treated at the antituberculosis dispensaries].
    Rudoĭ NM
    Klin Med (Mosk); 1975 Jan; 53(1):131-3. PubMed ID: 1134012
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002).
    Negi SS; Gupta S; Lal S
    J Commun Dis; 2003 Jun; 35(2):74-81. PubMed ID: 15562952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of use of bone marrow cells in therapy for experimental tuberculosis].
    Pospelov LE; Isaev AA; Bocharova IV; Avdienko VG; Babaian SS; Pospelov AL; Guseva AN; Gergert VIa
    Probl Tuberk Bolezn Legk; 2006; (10):60-3. PubMed ID: 17139835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Tuberculosis prevention in the light of new knowledge of the activity of antituberculosis drugs].
    MAZZETTI G
    Rass Clin Sci; 1958; 34(8-9):209-16. PubMed ID: 13591556
    [No Abstract]   [Full Text] [Related]  

  • 38. [Tuberculosis prevention in the light of new knowledge of the activity of antituberculosis drugs].
    MAZZETTI G
    Sperimentale; 1957; 107(6):510-3. PubMed ID: 13543532
    [No Abstract]   [Full Text] [Related]  

  • 39. [Solidarietà; section of the Antituberculosis League of Ticino].
    AIROLDI L
    Bibl Tuberc; 1954; 7():352-3. PubMed ID: 13172163
    [No Abstract]   [Full Text] [Related]  

  • 40. [Antituberculosis drugs].
    PERSHIN GN
    Farmakol Toksikol; 1958; 21(3):86-94. PubMed ID: 13562194
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.